INDIANAPOLIS, Nov. 19, 2024 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) announced today that it has elected Jon Moeller as a new member of its board of directors, effective Dec. 1, 2024. In ...

No arrests have been made. Two people were killed and 11 others were hurt in two shootings that erupted 45 minutes apart near a second line parade in New Orleans on Sunday afternoon, authorities said.

CHICAGO, Nov 18 (Reuters) - The highest dose of an experimental pill developed by Eli Lilly (LLY.N), opens new tab dramatically lowered an inherited form of high cholesterol in a mid-stage trial ...

However, as investors, we care about the stock price years down the line and what Eli ... We expect Eli Lilly’s P/E ratio in 2025 to be 60 with an EPS of $19.11, resulting in a price target ...

Eli Lilly shares tumble 12.5% in November, on track for their worst monthly performance since February 2009’s 20.2% drop. Past sell-offs signal resilience: LLY averaged double-digit rebounds one ...

18, 2024 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) today announced positive Phase 2 results for muvalaplin, an investigational once-daily, orally administered selective inhibitor of ...

Eli Lilly stock struggles despite 27% gains over the past year; RFK Jr.'s HHS appointment sparks GLP-1 drug fears. Analysts see long-term growth for obesity drugs; market panic could offer a buy ...

— Lilly to Develop Two Targets Identified and Validated Using Verge Genomics’ AI-Enabled, All-in-Human CONVERGE® Platform — Demonstration of the Robust Predictive Power of CONVERGE® - 83% ...

Nov 20 (Reuters) - Eli Lilly (LLY.N), opens new tab and Hong Kong-listed Laekna (2105.HK), opens new tab will collaborate to develop an experimental obesity drug that aims to help patients lose ...